Bharat Immunologicals & Biologicals Corporation Limited (BIBCL) Share Price
BSE · Healthcare · Biotechnology · ISIN INE994B01014
₹15.86-0.10 (-0.63%)
Key metrics
- Market Cap
- ₹68 Cr
- P/E Ratio
- —
- EPS
- -3.25
- Book Value
- 20.43
- P/B Ratio
- 0.78
- ROE
- -18.86%
- ROCE
- -10.1%
- Debt / Equity
- 0.8
- Net Margin
- -37.3%
- Revenue Growth
- -43.09%
- Profit Growth
- -90.08%
- Dividend Yield
- —
- 52W High
- ₹23.13
- 52W Low
- ₹14.10
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2023-03-31.
About Bharat Immunologicals & Biologicals Corporation Limited
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.
- Headquarters
- Bulandshahr, India
- Promoter Holding
- 59.25%
The full Bharat Immunologicals & Biologicals Corporation Limited analysis
Create a free account to open the complete BIBCL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.